SCHEMBL21935673

SCHEMBL21935673

Cn1cc(-c2ccc(Cc3cc(C(=O)NC4CCCCC4)nc4c3OCC4)cn2)cn1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 12/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21935412 0.94 CHRM1 (0.71) CHRM1
SCHEMBL31668928 0.90 CHRM1 (0.62) CHRM1
SCHEMBL21873404 0.90 CHRM1 (0.62) CHRM1
SCHEMBL31668985 0.86 CHRM1 (0.65) CHRM1
SCHEMBL21873382 0.86 CHRM1 (0.65) CHRM1
SCHEMBL30428359 0.85 CHRM1 (0.49) CHRM1
SCHEMBL21873400 0.85 CHRM1 (0.49) CHRM1
SCHEMBL21873365 0.84 CHRM1 (0.49) CHRM1
SCHEMBL18756185 0.84 CHRM1 (0.64) CHRM1
SCHEMBL30428197 0.84 CHRM1 (0.49) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643718-B1 HETEROCYCLIC COMPOUND AND ITS USE AS POSITIVE ALLOSTERIC MODULATOR OF THE CHOLINERGIC MUSCARINIC M1 RECEPTOR. TAKEDA PHARMACEUTICALS CO (JP) 2023-07-26 EP disclosed
EP-3643718-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-04-29 EP disclosed